StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Somil Mehta, Sharekhan

BUYSun Pharmaceutical Industries Ltd.

bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via CNBC Awaaz.

Entry₹1,884Inferred
Target₹2,000
Total upside +6.16%
Stop loss₹1,830-2.87% risk
CMP₹1,8655h ago
Active-1.01%+7.24%upside left 12d left
Follow Somil Mehta for new calls(24% target hit, 204 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 1 other Swing call on SUNPHARMASee 257 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Sept, 10:07 pm IST
3 supporting1 neutral2 opposing
Supports the BUY call (3)

5 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·23 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Sept · 2d ago

Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore

NewsGoogle News·20 Sept · 3d ago

(opens in new tab)
Neutral / worth noting (1)

Sun Pharmaceutical Industries Ltd has been assigned international issuer credit ratings by Moody's Ratings (Baa1, Stable Outlook) and S&P Global Ratings (BBB+, Stable Outlook). These ratings are inves

BSE · Company Update·8 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·23 Sept · today

Sun Pharma subsidiaries settle US generic drug pricing antitrust case for confidential amount

NewsCnbc-Tv18·11 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.